BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.650
-0.060 (-2.21%)
Mar 6, 2026, 4:00 PM EST - Market closed

BioLineRx Market Cap

BioLineRx has a market cap or net worth of $12.68 million as of March 6, 2026. Its market cap has decreased by -3.09% in one year.

Market Cap
12.68M
Enterprise Value
-2.15M
1-Year Change
-3.09%
Ranking
Category
Stock Price
$2.65

Market Cap Chart

Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $12.68M, a decrease of -62.49%. That is a compound annual growth rate of -5.73%.

History

DateMarket Cap% Change
Mar 6, 202612.68M-3.25%
Dec 31, 202513.10M-44.21%
Dec 31, 202423.49M-79.62%
Dec 31, 2023115.26M305.33%
Dec 29, 202228.44M-71.41%
Dec 30, 202199.46M66.19%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Curis 13.56M
Jupiter Neurosciences 13.32M
OSR Holdings 13.18M
Kairos Pharma 13.12M
Traws Pharma 12.79M
NewcelX 12.63M
BioCardia 12.52M
Phio Pharmaceuticals 12.49M
Market Cap Rankings